Study of the effect of pomegranate seed in diabetes

Study of the therapeutic effect of pomegranate seed in reducing fasting blood glucose, glycosylated hemoglobin, triglyceride and blood cholesterol in patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170125032171N2

Enrollment

Registered

2018-05-01

Start date

2017-09-07

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 2. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: This group receives tea bags of 5 grams of pomegranate seed powder twice a day for 8 weeks. Intervention 2: Control group: This group receives tea bags of 5 grams

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosis of type 2 diabetes for between one and ten years Taking metformin and glibenclamide tablets

Exclusion criteria

Exclusion criteria: Heart disease Insulin injection Body mass index (BMI) above 35 kg / m2 Breastfeeding kidney problems thyroid dysfunction pregnancy

Design outcomes

Primary

Measure	Time frame
Blood glucose. Timepoint: Before the intervention and 8 weeks after starting. Method of measurement: Measuring blood sugar level in the laboratory.;Glycosylated hemoglobin. Timepoint: Before the intervention and 8 weeks after starting. Method of measurement: Measuring blood sugar level in the laboratory.;Triglyceride. Timepoint: Before the intervention and 8 weeks after starting. Method of measurement: Measuring blood sugar level in the laboratory.;Cholestrol. Timepoint: Before the intervention and 8 weeks after starting. Method of measurement: Measuring blood sugar level in the laboratory.	—

Measure

Time frame

Blood glucose. Timepoint: Before the intervention and 8 weeks after starting. Method of measurement: Measuring blood sugar level in the laboratory.;Glycosylated hemoglobin. Timepoint: Before the intervention and 8 weeks after starting. Method of measurement: Measuring blood sugar level in the laboratory.;Triglyceride. Timepoint: Before the intervention and 8 weeks after starting. Method of measurement: Measuring blood sugar level in the laboratory.;Cholestrol. Timepoint: Before the intervention and 8 weeks after starting. Method of measurement: Measuring blood sugar level in the laboratory.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMonire Seyed Hashemi

Yazd University of Medical Sciences

m.seiedhashemi@yahoo.com+98 35 3728 0226

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026